23andMe sold out of bankruptcy to Regeneron
US drugmaker Regeneron has agreed to purchase genetics testing start-up 23andMe out of bankruptcy for $256 million, following the company's ...
US drugmaker Regeneron has agreed to purchase genetics testing start-up 23andMe out of bankruptcy for $256 million, following the company's ...
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.